Skip to main content
. 2019 Jul 13;38(3):709–716. doi: 10.1007/s00345-019-02853-0

Table 2.

Multivariate analysis of combinations of factors associated with UCB patient outcomes (mortality)

Combined variable Univariate Multivariate
P HR 95% CI P
Stabilin-1INT+ Mφs and age < 0.001 1.77 1.425–2.199 < 0.001
 Low stabilin-1INT+ Mφ density, age ≤ 60 1
 Low stabilin-1INT+ Mφ density, age > 60 3.53 1.693–7.355 0.001
 High stabilin-1INT+ Mφ density, age ≤ 60 2.3 1.011–5.239 0.047
 High stabilin-1INT+ Mφ density, age > 60 8.38 3.974–17.651 < 0.001
Stabilin-1INT+ Mφs and T stage < 0.001 1.7 1.387–2.092 < 0.001
 Low stabilin-1INT+ Mφ density, Ta–T1 1
 Low stabilin-1INT+ Mφ density, T2–T4 2.22 1.133–4.358 0.02
 High stabilin-1INT+ Mφ density, Ta–T1 1.98 1.030–3.795 0.04
 High stabilin-1INT+ Mφ density, T2–T4 6.23 3.318–11.689 < 0.001
Stabilin-1INT+ Mφs and nodal status < 0.001 1.61 1.294–2.013 < 0.001
 Low stabilin-1INT+ Mφ density, N0 1
 Low stabilin-1INT+ Mφ density, N1–N2 4.02 1.493–10.832 0.006
 High stabilin-1INT+ Mφ density, N0 2.56 1.566–4.187 < 0.001
 High stabilin-1INT+ Mφ density, N1–N2 5.28 1.933–14.431 0.001

Univariate and multivariate analyses. Cox proportional hazards regression model. Variables associated with survival by univariate analysis were adopted as covariates in multivariate analyses. Significant P values are shown in bold

UCB urothelial carcinoma of the bladder, Stabilin-1INT+Mφs stabilin-1+ Mφs in intratumoral regions, HR hazard ratio, CI confidence interval, NA not applicable

HR > 1, higher risk of death; HR < 1, lower risk of death